跳至主要内容
临床试验/NCT07215351
NCT07215351已完成不适用

Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women

University of Memphis3 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年10月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
3
主要终点
Mean corpuscular hemoglobin

研究概览

简要总结

The purpose of the present study is to investigate the impact of a natural dietary supplement, Inno Cleanse™, to reduce bloating in a population of otherwise healthy men and women, who claim to feel frequently bloated. Inno CleanseTM dietary supplement is manufactured in the United States under current Good Manufacturing Practices (cGMP) and is marketed by InnoSupps as a digestive health aid. It is sold in the United States on the company's website, Amazon, and in many large retail outlets. It remains a very popular product, with close to 1.4 million units sold since 2020, with a reported 66,000 units sold in the past three months.

Despite the prevalence of dietary supplements identifying as digestive aids, detoxification, and cleanses, very little research has been done to determine their effectiveness. The product appears to be well-designed, with multiple ingredients included which have scientific evidence of effectiveness. That said, and despite the overall positive reviews, there is no known clinical research to support the product's effectiveness.

Therefore, the aim of this study is to evaluate the efficacy of the Inno Cleanse product to reduce bloating and result in other positive outcomes (weight loss). This study will be run as a double-blind placebo-controlled trial, in which subjects will use the product or placebo for two weeks. It is hypothesized that treatment with the dietary supplement Inno Cleanse will result in reduced bloating, as evidenced by self-reported reductions in bloating and hunger, as well as moderate weight loss and a reduction in body circumference measures due to the reduced bloating. In addition, multiple anecdotal reports of improved skin health have been noted in those using the product. Additionally, routine blood and urine sample analysis will be performed as a secondary outcome, as a safety measure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • experience regular (2 or more days per week) bloating or constipation
  • able to fast a minimum of 12 hours prior to testing visit

排除标准

  • pregnant, planning to become pregnant, or breastfeeding
  • sensitivity or allergic to any components of the study product (cascara sagrada bark powder, cape aloe leaves extract, senna leaf powder, frangula bark powder fennel seed powder, bentonite clay, burdock root powder, licorice root extract, slippery elm bark powder, Capiscum annuum L. Fruit powder, milk thistle seed powder, hydroxypropyl methylcellulose, cellulose, and silicon dioxide).
  • experienced a severe allergic reaction that resulted in emergency care
  • diagnosed with medical disorders linked to digestive/gut health such as celiac disease, crohn's disease, gastroesophageal reflux disease, heartburn, irritable bowel syndrome, ulcerative colitis, ulcers, etcetera.
  • experiencing regular diarrhea
  • active infection or illness
  • hypertensive
  • cardiovascular disease
  • breast, uterine, or ovarian cancer
  • uterine fibroids or endometriosis
  • taking medications or supplements that may alter gut health including but not limited to diuretics, laxatives, anti-diarrheal, anticholinergic agents, or antispasmodic agents.
  • previous adverse experience with laxatives
  • taking medications known to interact with the dietary supplement's ingredients including blood pressure medications, anticoagulants, antiplatelets, blood thinners, cholesterol-lowering medications, diuretics, water pills, estrogen based contraceptives, non-steroidal anti-inflammatory drugs, digoxin, corticosteroids, Monoamine oxidase inhibitors, insulin, medications processed in the liver, diclofenac, fluvastatin, glipizide, ibuprofen, piroxicam, phenytoin, phenobarbital, or secobarbital.
  • tobacco user
  • strenuous activity within 24 hours of testing visits
  • caffeine within 24 hours of testing visit
  • alcohol within 24 hours of testing visit

研究组 & 干预措施

Experimental Dietary Supplement

Experimental

15 randomly assigned individuals will receive 2 capsules daily of the experimental dietary supplement for 2 weeks with assessments prior and after intervention.

干预措施: Dietary supplement for digestive health (Dietary Supplement)

Placebo Control

Placebo Comparator

15 randomly assigned individuals will receive 2 capsules daily of the placebo for 2 weeks with assessments prior and after intervention.

干预措施: placebo capsule (Dietary Supplement)

结局指标

主要结局

Mean corpuscular hemoglobin

时间窗: 2 weeks of assigned intervention

Mean corpuscular hemoglobin as part of a complete blood count panel measured in picograms

Mean corpuscular hemoglobin concentration

时间窗: 2 weeks of assigned intervention

Mean corpuscular hemoglobin concentration as part of a complete blood count panel measured in grams per deciliter

Red cell distribution width

时间窗: 2 weeks of assigned intervention

Red cell distribution width as part of a complete blood count panel measured as a percentage

Platelets

时间窗: 2 weeks of assigned intervention

Platelets as part of a complete blood count panel measured as a count per 1000 per microliter

Specific gravity

时间窗: 2 weeks of assigned intervention

Specific gravity as measured as part of urinalysis (no units)

pH

时间窗: 2 weeks of assigned intervention

pH as measured as part of urinalysis (no units)

Urine color

时间窗: 2 weeks of assigned intervention

Urine color as reported as part of urinalysis (no units)

Urine Appearance

时间窗: 2 weeks of assigned intervention

Urine Appearance as reported as part of urinalysis (no units)

White Blood Cell esterase

时间窗: baseline

White blood cell esterase as measured as part of urinalysis, if present

White blood cell esterase

时间窗: 2 weeks of assigned intervention

White blood cell esterase as measured as part of urinalysis, if present

Protein

时间窗: 2 weeks of assigned intervention

Protein as measured as part of urinalysis, if present

Glucose

时间窗: 2 weeks of assigned intervention

Glucose as measured as part of urinalysis, if present

Ketones

时间窗: 2 weeks of assigned intervention

Ketones as measured as part of urinalysis, if present

Occult blood

时间窗: 2 weeks of assigned intervention

Occult blood as measured as part of urinalysis, if present

Bilirubin

时间窗: 2 weeks of assigned intervention

Bilirubin as measured as part of urinalysis, if present

Urobilinogen

时间窗: 2 weeks of assigned intervention

Urobilinogen as measured as part of urinalysis in milligrams per deciliter

Microscopic examination

时间窗: 2 weeks of assigned intervention

Microscopic examination as reported as part of urinalysis, if indicated

Total Cholesterol

时间窗: 2 weeks of assigned intervention

Total Cholesterol as reported as part of lipid panel in milligrams per deciliter

Triglycerides

时间窗: 2 weeks of assigned intervention

Triglycerides as reported as part of lipid panel in milligrams per deciliter

High-Density Lipoprotein Cholesterol

时间窗: 2 weeks of assigned intervention

High-Density Lipoprotein Cholesterol as reported as part of lipid panel in milligrams per deciliter

Very Low-Density Lipoprotein Cholesterol

时间窗: 2 weeks of assigned intervention

Very Low-Density Lipoprotein Cholesterol as reported as part of lipid panel in milligrams per deciliter

Low-Density Lipoprotein Cholesterol

时间窗: 2 weeks of assigned intervention

Low-Density Lipoprotein Cholesterol as reported as part of lipid panel in milligrams per deciliter

Calcium

时间窗: 2 weeks of assigned intervention

Calcium measured as part of metabolic panel in milligrams per deciliter

Carbon dioxide

时间窗: 2 weeks of assigned intervention

Carbon dioxide measured as part of metabolic panel in millimoles per liter

Chloride

时间窗: 2 weeks of assigned intervention

Chloride measured as part of metabolic panel in millimoles per liter.

Creatinine

时间窗: 2 weeks of assigned intervention

Creatinine measured as part of metabolic panel in milligrams per deciliter

Estimated glomerular filtration rate

时间窗: 2 weeks of assigned intervention

Estimated glomerular filtration rate as part of metabolic panel in milliliters per minute per 1.73

Blood Glucose

时间窗: 2 weeks of assigned intervention

Glucose measured as part of metabolic panel in milligrams per deciliter

Potassium

时间窗: 2 weeks of assigned intervention

Potassium measured as part of metabolic panel in millimoles per liter.

Sodium

时间窗: 2 weeks of assigned intervention

Sodium measured as part of metabolic panel in millimoles per liter.

Total Globulin

时间窗: 2 weeks of assigned intervention

Total Globulin measured as part of metabolic panel in grams per deciliter

Total Protein

时间窗: 2 weeks of assigned intervention

Total Protein measured as part of metabolic panel in grams per deciliter

Albumin/globulin ratio

时间窗: 2 weeks of assigned intervention

Albumin/globulin ratio measured as part of metabolic panel

Blood urea nitrogen/creatinine ratio

时间窗: 2 weeks of assigned intervention

Blood urea nitrogen/creatinine ratio measured as part of metabolic panel

Hematocrit

时间窗: 2 weeks of assigned intervention

Hematocrit as part of a complete blood count panel measured as percentage

Hemoglobin

时间窗: 2 weeks of assigned intervention

Hemoglobin as part of a complete blood count panel measured in grams per deciliter

Mean corpuscular volume

时间窗: 2 weeks of assigned intervention

Mean corpuscular volume as part of a complete blood count panel measured in femtoliters

Blood urea nitrogen

时间窗: 2 weeks of assigned intervention

Blood urea nitrogen measured as part of metabolic panel in milligrams per deciliter

Alanine transaminase

时间窗: 2 weeks of assigned intervention

Alanine transaminase measured as part of metabolic panel in international units per liter

Aspartate transferase

时间窗: 2 weeks of assigned intervention

Aspartate transferase measured as part of metabolic panel in international units per liter

Albumin

时间窗: 2 weeks of assigned intervention

Albumin measured as part of metabolic panel in grams per deciliter

Alkaline phosphatase

时间窗: 2 weeks of assigned intervention

Alkaline phosphatase measured as part of metabolic panel in international units per liter

Total bilirubin

时间窗: baseline

Total bilirubin measured as part of metabolic panel in milligrams per deciliter

Total Bilirubin

时间窗: 2 weeks of assigned intervention

Total bilirubin measured as part of metabolic panel in milligrams per deciliter

Mood questionnaire

时间窗: 2 weeks of assigned intervention

Visual analog scale used to assess mood (attentive, tired, alert, groggy, focused, sluggish, energetic, lethargic, fatigued, mental clarity, motivation, happiness, and feeling from 0 (None) to 10 (Extreme) as well as "Flushed out" from 0 (not at all) to 10 (completely empty)

36-item short form survey

时间窗: 2 weeks of assigned intervention

36-item questionnaire that measures health-related quality of life with responses used to calculate scores on a scale of 0-100, where higher scores indicate better health.

Tolerability Questionnaire

时间窗: 2 weeks of assigned treatment

18 item questionnaire covering upper abdominal, lower abdominal, and other symptoms using a 0-9 scale (0-no problem at all to 9-the worst it has ever been)

Bristol Chart

时间窗: 14 days of assigned treatment

Self-reported number and consistency of daily bowel movements

Weight

时间窗: 2 weeks of assigned treatment

Body weight measured in kg

Skin age

时间窗: 2 weeks of assigned treatment

a quantitative skin age based on skin parameters will be determined by the 3D P Plus system

Alanine transaminase

时间窗: 2 weeks of assigned intervention

Alanine transaminase measured as part of metabolic panel in international units per liter

Aspartate transferase

时间窗: 2 weeks of assigned intervention

Aspartate transferase measured as part of metabolic panel in international units per liter

Albumin

时间窗: 2 weeks of assigned intervention

Albumin measured as part of metabolic panel in grams per deciliter

Alkaline phosphatase

时间窗: 2 weeks of assigned intervention

Alkaline phosphatase measured as part of metabolic panel in international units per liter

Total bilirubin

时间窗: baseline

Total bilirubin measured as part of metabolic panel in milligrams per deciliter

Total Bilirubin

时间窗: 2 weeks of assigned intervention

Total bilirubin measured as part of metabolic panel in milligrams per deciliter

Blood urea nitrogen

时间窗: 2 weeks of assigned intervention

Blood urea nitrogen measured as part of metabolic panel in milligrams per deciliter

Calcium

时间窗: 2 weeks of assigned intervention

Calcium measured as part of metabolic panel in milligrams per deciliter

Carbon dioxide

时间窗: 2 weeks of assigned intervention

Carbon dioxide measured as part of metabolic panel in millimoles per liter

Chloride

时间窗: 2 weeks of assigned intervention

Chloride measured as part of metabolic panel in millimoles per liter.

Creatinine

时间窗: 2 weeks of assigned intervention

Creatinine measured as part of metabolic panel in milligrams per deciliter

Estimated glomerular filtration rate

时间窗: 2 weeks of assigned intervention

Estimated glomerular filtration rate as part of metabolic panel in milliliters per minute per 1.73

Blood Glucose

时间窗: 2 weeks of assigned intervention

Glucose measured as part of metabolic panel in milligrams per deciliter

Potassium

时间窗: 2 weeks of assigned intervention

Potassium measured as part of metabolic panel in millimoles per liter.

Sodium

时间窗: 2 weeks of assigned intervention

Sodium measured as part of metabolic panel in millimoles per liter.

Total Globulin

时间窗: 2 weeks of assigned intervention

Total Globulin measured as part of metabolic panel in grams per deciliter

Total Protein

时间窗: 2 weeks of assigned intervention

Total Protein measured as part of metabolic panel in grams per deciliter

Albumin/globulin ratio

时间窗: 2 weeks of assigned intervention

Albumin/globulin ratio measured as part of metabolic panel

Blood urea nitrogen/creatinine ratio

时间窗: 2 weeks of assigned intervention

Blood urea nitrogen/creatinine ratio measured as part of metabolic panel

Hematocrit

时间窗: 2 weeks of assigned intervention

Hematocrit as part of a complete blood count panel measured as percentage

Hemoglobin

时间窗: 2 weeks of assigned intervention

Hemoglobin as part of a complete blood count panel measured in grams per deciliter

Mean corpuscular volume

时间窗: 2 weeks of assigned intervention

Mean corpuscular volume as part of a complete blood count panel measured in femtoliters

Mean corpuscular hemoglobin

时间窗: 2 weeks of assigned intervention

Mean corpuscular hemoglobin as part of a complete blood count panel measured in picograms

Mean corpuscular hemoglobin concentration

时间窗: 2 weeks of assigned intervention

Mean corpuscular hemoglobin concentration as part of a complete blood count panel measured in grams per deciliter

Red cell distribution width

时间窗: 2 weeks of assigned intervention

Red cell distribution width as part of a complete blood count panel measured as a percentage

Platelets

时间窗: 2 weeks of assigned intervention

Platelets as part of a complete blood count panel measured as a count per 1000 per microliter

Specific gravity

时间窗: 2 weeks of assigned intervention

Specific gravity as measured as part of urinalysis (no units)

pH

时间窗: 2 weeks of assigned intervention

pH as measured as part of urinalysis (no units)

Urine color

时间窗: 2 weeks of assigned intervention

Urine color as reported as part of urinalysis (no units)

Urine Appearance

时间窗: 2 weeks of assigned intervention

Urine Appearance as reported as part of urinalysis (no units)

White Blood Cell esterase

时间窗: baseline

White blood cell esterase as measured as part of urinalysis, if present

White blood cell esterase

时间窗: 2 weeks of assigned intervention

White blood cell esterase as measured as part of urinalysis, if present

Protein

时间窗: 2 weeks of assigned intervention

Protein as measured as part of urinalysis, if present

Glucose

时间窗: 2 weeks of assigned intervention

Glucose as measured as part of urinalysis, if present

Ketones

时间窗: 2 weeks of assigned intervention

Ketones as measured as part of urinalysis, if present

Occult blood

时间窗: 2 weeks of assigned intervention

Occult blood as measured as part of urinalysis, if present

Bilirubin

时间窗: 2 weeks of assigned intervention

Bilirubin as measured as part of urinalysis, if present

Urobilinogen

时间窗: 2 weeks of assigned intervention

Urobilinogen as measured as part of urinalysis in milligrams per deciliter

Microscopic examination

时间窗: 2 weeks of assigned intervention

Microscopic examination as reported as part of urinalysis, if indicated

Total Cholesterol

时间窗: 2 weeks of assigned intervention

Total Cholesterol as reported as part of lipid panel in milligrams per deciliter

Very Low-Density Lipoprotein Cholesterol

时间窗: 2 weeks of assigned intervention

Very Low-Density Lipoprotein Cholesterol as reported as part of lipid panel in milligrams per deciliter

Low-Density Lipoprotein Cholesterol

时间窗: 2 weeks of assigned intervention

Low-Density Lipoprotein Cholesterol as reported as part of lipid panel in milligrams per deciliter

Triglycerides

时间窗: 2 weeks of assigned intervention

Triglycerides as reported as part of lipid panel in milligrams per deciliter

High-Density Lipoprotein Cholesterol

时间窗: 2 weeks of assigned intervention

High-Density Lipoprotein Cholesterol as reported as part of lipid panel in milligrams per deciliter

Mood questionnaire

时间窗: 2 weeks of assigned intervention

Visual analog scale used to assess mood (attentive, tired, alert, groggy, focused, sluggish, energetic, lethargic, fatigued, mental clarity, motivation, happiness, and feeling from 0 (None) to 10 (Extreme) as well as "Flushed out" from 0 (not at all) to 10 (completely empty)

36-item short form survey

时间窗: 2 weeks of assigned intervention

36-item questionnaire that measures health-related quality of life with responses used to calculate scores on a scale of 0-100, where higher scores indicate better health.

Tolerability Questionnaire

时间窗: 2 weeks of assigned treatment

18 item questionnaire covering upper abdominal, lower abdominal, and other symptoms using a 0-9 scale (0-no problem at all to 9-the worst it has ever been)

Weight

时间窗: 2 weeks of assigned treatment

Body weight measured in kg

Diastolic blood pressure

时间窗: 2 weeks of assigned treatment

Diastolic blood pressure will be measured using an automated blood pressure machine in units millimeters of mercury

Bristol Chart

时间窗: 14 days of assigned treatment

Self-reported number and consistency of daily bowel movements

Skin age

时间窗: 2 weeks of assigned treatment

a quantitative skin age based on skin parameters will be determined by the 3D P Plus system

Heart rate

时间窗: baseline

Heart rate will be measured using an automated blood pressure machine in units beats per minute

Heart Rate

时间窗: 2 weeks of assigned treatment

Hear rate will be measured using an automated blood pressure machine in units beats per minute

Systolic blood pressure

时间窗: 2 weeks of assigned treatment

Systolic blood pressure will be measured using an automated blood pressure machine in units millimeters of mercury

次要结局

  • Daily food diary(1 day prior to 2 week visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Richard Bloomer

Dean of College of Health Sciences

University of Memphis

研究点 (3)

Loading locations...

相似试验